Date:
Monday, August 1, 2022
The European Cystic Fibrosis Society is pleased to announce that the official 2021 Impact Factors (IF) were recently released, and the Journal of Cystic Fibrosis (JCF) has increased its IF from the 2020 IF of 5.482 to 5.527. JCF ranks 18th in the Respiratory System category.
The Journal Impact Factor is published each year by Thomson Reuters. It is a measure of the number of times an average paper in a particular journal is cited during the preceding two years.
The ECFS would like to thank the Editor in Chief, Dr. Patrick Flume, and the Editorial Board. Their excellent work has helped JCF gain its current standings and continues to aid its growth.